These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 35677421)

  • 21. The differences in SARS-CoV and SARS-CoV-2 specific co-expression network mediated biological process in human gut enterocytes.
    Nayak T; De D; Dhal PK
    Infect Genet Evol; 2021 Aug; 92():104892. PubMed ID: 33957338
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SARS-CoV-2 promotes RIPK1 activation to facilitate viral propagation.
    Xu G; Li Y; Zhang S; Peng H; Wang Y; Li D; Jin T; He Z; Tong Y; Qi C; Wu G; Dong K; Gou J; Liu Y; Xiao T; Qu J; Li L; Liu L; Zhao P; Zhang Z; Yuan J
    Cell Res; 2021 Dec; 31(12):1230-1243. PubMed ID: 34663909
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identifying potential drug targets and candidate drugs for COVID-19: biological networks and structural modeling approaches.
    Selvaraj G; Kaliamurthi S; Peslherbe GH; Wei DQ
    F1000Res; 2021; 10():127. PubMed ID: 33968364
    [No Abstract]   [Full Text] [Related]  

  • 24. Molecular Insights of SARS-CoV-2 Infection and Molecular Treatments.
    Abdurrahman L; Fang X; Zhang Y
    Curr Mol Med; 2022; 22(7):621-639. PubMed ID: 34645374
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Network analytics for drug repurposing in COVID-19.
    Siminea N; Popescu V; Sanchez Martin JA; Florea D; Gavril G; Gheorghe AM; Iţcuş C; Kanhaiya K; Pacioglu O; Popa LL; Trandafir R; Tusa MI; Sidoroff M; Păun M; Czeizler E; Păun A; Petre I
    Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34864885
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis.
    Guo S; Lei X; Chang Y; Zhao J; Wang J; Dong X; Liu Q; Zhang Z; Wang L; Yi D; Ma L; Li Q; Zhang Y; Ding J; Liang C; Li X; Guo F; Wang J; Cen S
    Signal Transduct Target Ther; 2022 Dec; 7(1):400. PubMed ID: 36575184
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Screening druggable targets and predicting therapeutic drugs for COVID-19 via integrated bioinformatics analysis.
    Tan S; Chen W; Xiang H; Kong G; Zou L; Wei L
    Genes Genomics; 2021 Jan; 43(1):55-67. PubMed ID: 33428154
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Repurposing potential of FDA-approved and investigational drugs for COVID-19 targeting SARS-CoV-2 spike and main protease and validation by machine learning algorithm.
    Verma AK; Aggarwal R
    Chem Biol Drug Des; 2021 Apr; 97(4):836-853. PubMed ID: 33289334
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug repurposing for COVID-19 using computational screening: Is Fostamatinib/R406 a potential candidate?
    Saha S; Halder AK; Bandyopadhyay SS; Chatterjee P; Nasipuri M; Bose D; Basu S
    Methods; 2022 Jul; 203():564-574. PubMed ID: 34455072
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of potential therapeutic targets and mechanisms of COVID-19 through network analysis and screening of chemicals and herbal ingredients.
    Wang H; Zhang J; Lu Z; Dai W; Ma C; Xiang Y; Zhang Y
    Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34505138
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Network Theoretical Approach to Explore Factors Affecting Signal Propagation and Stability in Dementia's Protein-Protein Interaction Network.
    Lalwani AK; Krishnan K; Bagabir SA; Alkhanani MF; Almalki AH; Haque S; Sharma SK; Singh RKB; Malik MZ
    Biomolecules; 2022 Mar; 12(3):. PubMed ID: 35327643
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SARS-CoV-2 induces "cytokine storm" hyperinflammatory responses in RA patients through pyroptosis.
    Zheng Q; Lin R; Chen Y; Lv Q; Zhang J; Zhai J; Xu W; Wang W
    Front Immunol; 2022; 13():1058884. PubMed ID: 36532040
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lung disease network reveals impact of comorbidity on SARS-CoV-2 infection and opportunities of drug repurposing.
    Das AB
    BMC Med Genomics; 2021 Sep; 14(1):226. PubMed ID: 34535131
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Repurposing Ayush-64 for COVID-19: A Computational Study Based on Network Pharmacology and Molecular Docking.
    K C M; K A AN
    Comb Chem High Throughput Screen; 2022; 25(12):2089-2102. PubMed ID: 35142268
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exploring potential mechanisms of Suhexiang Pill against COVID-19 based on network pharmacology and molecular docking.
    Li J; Huang Z; Lu S; Luo H; Tan Y; Ye P; Liu X; Wu Z; Wu C; Stalin A; Wang H; Liu Y; Shen L; Fan X; Zhang B; Yi J; Yao L; Xu Y; Wu J; Duan X
    Medicine (Baltimore); 2021 Dec; 100(51):e27112. PubMed ID: 34941025
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multi-Level Biological Network Analysis and Drug Repurposing Based on Leukocyte Transcriptomics in Severe COVID-19: In Silico Systems Biology to Precision Medicine.
    Sagulkoo P; Chuntakaruk H; Rungrotmongkol T; Suratanee A; Plaimas K
    J Pers Med; 2022 Jun; 12(7):. PubMed ID: 35887528
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Revealing the structural and molecular interaction landscape of the favipiravir-RTP and SARS-CoV-2 RdRp complex through integrative bioinformatics: Insights for developing potent drugs targeting SARS-CoV-2 and other viruses.
    Chakraborty C; Bhattacharya M; Saha A; Alshammari A; Alharbi M; Saikumar G; Pal S; Dhama K; Lee SS
    J Infect Public Health; 2023 Jul; 16(7):1048-1056. PubMed ID: 37196368
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Repurposing of gastric cancer drugs against COVID-19.
    Sonkar C; Doharey PK; Rathore AS; Singh V; Kashyap D; Sahoo AK; Mittal N; Sharma B; Jha HC
    Comput Biol Med; 2021 Oct; 137():104826. PubMed ID: 34537409
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Repositioning Therapeutics for SARS-CoV-2: Virtual Screening of Plant-based Anti-HIV Compounds as Possible Inhibitors against COVID-19 Viral RdRp.
    Murali M; Gowtham HG; Ansari MA; Alomary MN; Alghamdi S; Almehmadi M; Singh SB; Shilpa N; Aiyaz M; Kalegowda N; Ledesma AE; Amruthesh KN
    Curr Pharm Des; 2022; 28(12):969-980. PubMed ID: 35796443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.